| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Tvardi Therapeutics, Inc.
13G
CARA · 140755208
|
8.1% |
4/22/2025
Event 4/15/2025
|
||||
| Solas Tvardi Sidecar LLC | 8.1% | |||||
| Solas BioVentures Fund II, LP | 8.1% | |||||
| Solas Partners II, LLC | 8.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.